NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis

RecruitingNA

Sponsor: Primus Pharmaceuticals

Conditions: Scleroderma, Systemic, Digital Ulcer

Interventions: Diosmin, Placebo

Countries: Canada

This study is performed to consider the safety and healing ability of diosmin in patients with systemic sclerosis (scleroderma) and open sores on their fingers (digital ulcers). Two (2) out of three (3) participants will receive active product. The participants will have four (4) visits over eight (8) weeks. Physical exams and photos will be performed. A variety of questions will be asked describing level of pain and lifestyle changes.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Diagnosis of systemic sclerosis (scleroderma)
* At least one "active" digital ulcer
* Medication for systemic sclerosis unchanged for 30 days

Exclusion Criteria:

* Infection or gangrene in ulcer
* Citrus allergy
* Unstable heart, kidney, or liver disease
* Active infection of any type
* Current cancer treatment or uncured cancer
* Pregnancy or breast feeding

Locations (5)

Calgary, Alberta, Canada
Halifax, Nova Scotia, Canada
London, Ontario, Canada
Ottawa, Ontario, Canada
Toronto, Ontario, Canada